Somatostatin
- Generic Name
- Somatostatin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C76H104N18O19S2
- CAS Number
- 38916-34-6
- Unique Ingredient Identifier
- 6E20216Q0L
- Background
Somatostatin, also known as growth hormone-inhibiting hormone, is a naturally-occurring peptide hormone of 14 or 28 amino acid residues that regulates the endocrine system. It is secreted by the D cells of the islets to inhibit the release of insulin and glucagon, and is also generated in the hypothalamus, where it inhibits the release of growth hormone and...
- Indication
For the symptomatic treatment of acute bleeding from esophageal varices. Other treatment options for long-term management of the condition may be considered if necessary, once initial control has been established.
- Associated Conditions
- Acromegaly, Bleeding caused by Gastritis erosive, Diabetic Ketoacidosis, Duodenal ulcer haemorrhage, Fistula of small intestine, Fistula, Biliary, Gastric ulcer haemorrhage, Gastritis haemorrhagic, Oesophageal varices haemorrhage, Pancreatic Fistula, Postoperative Complications caused by Pancreatic Surgery
- Associated Therapies
- Restriction of Secretions
The Effect of Somatostatin for Treatment of Post Hepatectomy Liver Failure (PHLF)
- First Posted Date
- 2016-08-29
- Last Posted Date
- 2016-09-12
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT02882347
- Locations
- 🇰🇷
Korea university Anam hospital, Seoul, Korea, Republic of
Metabolic Consequences of Gastrointestinal Surgery
- Conditions
- Interventions
- First Posted Date
- 2016-07-19
- Last Posted Date
- 2019-04-02
- Target Recruit Count
- 81
- Registration Number
- NCT02836353
- Locations
- 🇬🇧
Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom
Vasoactive Drugs in Real World Practice
- Conditions
- Interventions
- First Posted Date
- 2016-05-02
- Last Posted Date
- 2016-05-03
- Lead Sponsor
- Kaohsiung Veterans General Hospital.
- Target Recruit Count
- 150
- Registration Number
- NCT02757703
- Locations
- 🇨🇳
Division of Gastroenterology, Department of Internal Medicine, Kaohsiung, Taiwan
In Vivo Assessment of Cellular Metabolism in Humans
- First Posted Date
- 2016-04-22
- Last Posted Date
- 2022-08-03
- Lead Sponsor
- K. Sreekumaran Nair
- Target Recruit Count
- 17
- Registration Number
- NCT02748369
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET
- First Posted Date
- 2015-12-16
- Last Posted Date
- 2015-12-16
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 30
- Registration Number
- NCT02631616
Impact of Endogenous E2 on SSI and GH Rebound
- Conditions
- Interventions
- First Posted Date
- 2014-01-03
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 62
- Registration Number
- NCT02026973
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Multi-center Clinical Study of Early Antibios of Severe Acute Pancreatitis
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- Erzhen Chen
- Target Recruit Count
- 60
- Registration Number
- NCT01992198
- Locations
- 🇨🇳
Depatrment of EICU,Ruijin Hospital, Shanghai, Shanghai, China
Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection
- Conditions
- Interventions
- First Posted Date
- 2013-08-02
- Last Posted Date
- 2013-08-02
- Target Recruit Count
- 2
- Registration Number
- NCT01914692
Effects of Canagliflozin on C-peptide Clearance in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2012-08-15
- Last Posted Date
- 2013-06-07
- Lead Sponsor
- Janssen-Cilag International NV
- Target Recruit Count
- 10
- Registration Number
- NCT01665638
Effects of Somatostatin on Post-endoscopic Portal Hemodynamic in Cirrhotic Patients With Esophageal Gastric Varices
- Conditions
- Interventions
- First Posted Date
- 2011-08-31
- Last Posted Date
- 2011-09-02
- Lead Sponsor
- Yunsheng Yang
- Target Recruit Count
- 126
- Registration Number
- NCT01426087
- Locations
- 🇨🇳
Site, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.